Drugs / CV0801
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05960097 | Aug 2023 → Aug 2024 | COVID-19 | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CV0801 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05960097 ↗ |
| Route | Intramuscular | “Study vaccine was administered as a single intramuscular injection.” NCT05960097 ↗ |